Introduction: In Burkina Faso, despite actions to improve women’s health, the percentage of those with unmet needs in terms of family planning remains high (35.6% in 2015 to 20.2% in 2018 according to projections from the Performance Monitoring and Accountability project [PMA2014-15/Burkina]).
Methods: The study used data from demographic and public health investigations as well as multiple indicator cluster surveys for Burkina Faso in 2010. Two analysis techniques were used: a Multiple Correspondence Analysis, then an Ascending Hierarchical Classification (AHC). A multi-level logistic regression model was used to estimate the net effects of individual and environmental factors associated with these unmet needs.
Results: The analysis of the random effects shows that the propensity of having unmet needs in terms of family planning varies considerable from one household to another and from one enumeration zone to another. The net effects also show that women between the ages of 35 and 49 are 6.94 times at risk of having unmet needs in terms of limiting births than for those aged 20 to 34. For the unmet need of spacing births, this risk is estimated at 69% less high for women between 35 to 49 years of age than for those aged 15 to 19.
Conclusion: It is necessary to strengthen local awareness programs geared towards women and their spouses about the benefits and the importance of family planning, while taking into account their sociodemographic characteristics (age, parity, ethnic background, living environment).
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3917/spub.201.0123 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Leveraging Administrative Health Databases to Address Health Challenges in Farming Populations: Scoping Review and Bibliometric Analysis (1975-2024).
JMIR Public Health Surveill
January 2025
Laboratoire AGEIS, Université Grenoble Alpes, La Tronche Cedex, France.
Background: Although agricultural health has gained importance, to date, much of the existing research relies on traditional epidemiological approaches that often face limitations related to sample size, geographic scope, temporal coverage, and the range of health events examined. To address these challenges, a complementary approach involves leveraging and reusing data beyond its original purpose. Administrative health databases (AHDs) are increasingly reused in population-based research and digital public health, especially for populations such as farmers, who face distinct environmental risks.
View Article and Find Full Text PDFThe Endocannabinoid Activity Remodulation for Psychosis Liability in Youth (EARLY) Study: An Open-Label Feasibility Trial of Ultramicronized-Palmitoylethanolamide Oral Supplementation in Clinical High-Risk State for Psychosis.
Brain Sci
December 2024
Unit of Psychiatry and Eating Disorders, Department of Medicine (DMED), University of Udine, 33100 Udine, Italy.
To date, no psychotropic medication has shown to effectively halt progression to psychosis among individuals at Clinical High-Risk for psychosis (CHR), fueling the search for novel therapeutic agents. Recent evidence supports Palmitoylethanolamide (PEA) signaling as a potential psychosis biomarker, also indicating a therapeutic role for its supplementation in the treatment of psychotic disorders. Nonetheless, the effect of sustained PEA intake in CHR subjects has never been explored so far.
View Article and Find Full Text PDF"I Am Longing and Afraid to Depend on You": A Case Report on Breakdowns of Therapeutic Alliance and Interpersonal Cycles in Complex Trauma.
Brain Sci
November 2024
Associazione di Psicologia Cognitiva APC e Scuola di Psicoterapia Cognitiva SPC, 00185 Rome, Italy.
Background: Patients with Complex Trauma (CT) may have an impaired ability to trust others and build intimate relationships due to non-integrated representations of self and others. This sometimes leads to an oscillation between needing and fearing intimacy in their adult relationships. This dynamic can occur in the therapeutic relationship, undermining the effectiveness of therapy and affecting the mental health of both the patient and the therapist.
View Article and Find Full Text PDFImmune Checkpoint Inhibitors in Glioblastoma IDHwt Treatment: A Systematic Review.
Cancers (Basel)
December 2024
Lou & Jean Malnati Brain Tumor Institute, Northwestern University, Chicago, IL 60611, USA.
Purpose: A glioblastoma (GBM) is a primary brain tumor with significant unmet therapeutic needs. Immune checkpoint inhibitors (ICIs) have marked therapeutic benefits in many different cancers but have yet to show benefit for most GBM patients in phase III trials.
Methods: A systematic review querying ClinicalTrials.
Pentoxifylline adjunct to risperidone for negative symptoms of stable schizophrenia: A randomized, double-blind, placebo-controlled trial.
Int J Neuropsychopharmacol
December 2024
Psychiatric Research Center, Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Background: Negative symptoms of schizophrenia represent an unmet therapeutic need for many patients on whom pentoxifylline may be effective in terms of its dopaminergic, anti-inflammatory, and cerebral blood flow-increasing properties. This study aimed to evaluate pentoxifylline as a therapeutic agent for improving negative symptoms of schizophrenia.
Methods: Chronic schizophrenia outpatients experiencing significant negative symptoms were randomly allocated to receive pentoxifylline 400 mg or matched placebo q12hr for eight weeks.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!